小分子介导的化学光动力学疗法诱导癌细胞的自和亡
Asima Sahu1, Tripti Mishra1, Pathi Arun Babu1
1Department of chemistry, Indian Institute of Technology (IIT) Gandhinagar, Palaj, Gandhinagar, Gujarat, 382355, India.
研究人员开发了一种新的小分子,化合物6a,用于癌症光疗. 这种分子通过产生活性氧物种 (ROS),对健康细胞具有最小的毒性,有效地杀死结肠癌细胞.
科学领域:
- 药用化学 医学化学
- 纳米技术 纳米技术
- 癌症生物学 癌症生物学
背景情况:
- 癌症仍然是全球主要的死亡原因,化疗导致严重的副作用.
- 光疗为癌症治疗提供了一个有前途的非侵入性替代方案.
- 为化学光疗开发有效的小分子是一个重大挑战.
研究的目的:
- 设计和合成用于光动力学癌症治疗的新型小分子.
- 为了识别具有向癌细胞杀死能力的强效化学光疗剂.
- 研究开发的化合物的作用机制和细胞吸收.
主要方法:
- 一个小分子库的合成,包括π-捐赠者,π电子丰富的药和π-接受者部分.
- 针对结肠 (HCT-116),宫 (HeLa) 和肺 (A549) 癌细胞系的合成化合物的查.
- 在体外和3D球形中评估化合物6a的疗效,ROS生成,细胞吸收,溶酶体向和毒性.
主要成果:
- 化合物6a在740nm的LED辐射下显示出显著的HCT-116癌细胞杀死.
- 它选择性地向癌细胞,对非癌性Cos-7细胞显示微不足道的毒性.
- 化合物6a自组装成纳米粒子,有效地向溶酶体,诱导自和ROS,导致细胞亡和亡.
结论:
- 化合物6a是一种强大的化学光疗剂,有效对抗结肠癌.
- 它的自我组装,向 lysosomes,并诱导ROS介导的细胞死亡的能力使其成为癌症治疗的有希望的候选人.
- 这种分子是开发用于癌症治疗的新型光动力学探针的宝贵工具.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
相关概念视频
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
